These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23106522)

  • 1. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
    Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
    Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
    Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
    CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
    Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L
    Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide: a review of its use in the management of adults with partial seizures.
    Hoy SM
    Drugs; 2013 Aug; 73(12):1321-38. PubMed ID: 23873520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy].
    Villanueva V; Serrano-Castro PJ
    Rev Neurol; 2013 Apr; 56(8):429-38. PubMed ID: 23568686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide in clinical practice.
    Dupont S; Stefan H
    Acta Neurol Scand Suppl; 2012; (194):29-35. PubMed ID: 23106523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide for the treatment of epilepsy.
    Arzimanoglou A; Rahbani A
    Expert Rev Neurother; 2006 Sep; 6(9):1283-92. PubMed ID: 17009916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial.
    Guerrini R; Rosati A; Bradshaw K; Giorgi L
    Epilepsia; 2014 Apr; 55(4):568-78. PubMed ID: 24621319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide clinical trials: European experience.
    Brodie MJ
    Seizure; 2004 Dec; 13 Suppl 1():S66-70; discussion S71-2. PubMed ID: 15511696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
    Kothare SV; Kaleyias J
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM.
    Hamer H; Baulac M; McMurray R; Kockelmann E
    Seizure; 2016 Jan; 34():66-73. PubMed ID: 26735004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.